Biblio Discovery — Demo Discovery Service

3 results for "Michael A. Singer"

Showing 1–3 · 0.35 seconds · RSS

  1. Journal Article

    Diabetic macular edema: it is more than just VEGF [version 1; referees: 2 approved]

    Michael A. Singer; Daniel S. Kermany; Jana Waters et al.

    F1000Research, Vol. 5 · 2016 · English · DOAJ Scopus

    Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have been used to treat this condition. In…

  2. Journal Article

    Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study

    Michael A. Singer; Charles C. Wykoff; Christopher D. Riemann et al.

    Therapeutic Advances in Ophthalmology, Vol. 18 · 2026 · English · DOAJ Scopus

    Summary This summary explains the findings of the NEW DAY study, which examined two ways of starting treatment for diabetic macular edema (DME). DME is an eye condition that can affect people with diabetes and can cause blurred vision or vision loss if not treated. In the 18-month study, adults…

  3. Journal Article

    Early adoption of triamcinolone acetonide suprachoroidal injection for uveitic macular edema: a physician survey

    Christopher R. Henry; Scott D. Walter; Peter Y. Chang et al.

    BMC Research Notes, Vol. 17 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Objective To obtain physicians’ “real-world” perspectives on early experiences with triamcinolone acetonide suprachoroidal injection (SCS-TA) for treatment of patients with uveitic macular edema (UME). Results Twelve retina/uveitis specialists in the United States were surveyed about…